TrialAIDS research and human retroviruses2014

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.

Charlotta Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.